# To Compare SH T00658ID Over Ortho Tri-Cyclen Lo (US/Canada)

> **NCT00754065** · PHASE3 · COMPLETED · sponsor: **Bayer** · enrollment: 409 (actual)

## Conditions studied

- Contraception

## Interventions

- **DRUG:** Estradiol valerate, Dienogest (Natazia, Qlaira, BAY86-5027)
- **DRUG:** Ortho Tri Cyclen Lo

## Key facts

- **NCT ID:** NCT00754065
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-09-08
- **Primary completion:** 2011-05-10
- **Final completion:** 2011-05-10
- **Target enrollment:** 409 (ACTUAL)
- **Last updated:** 2024-11-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00754065

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00754065, "To Compare SH T00658ID Over Ortho Tri-Cyclen Lo (US/Canada)". Retrieved via AI Analytics 2026-07-05 from https://api.ai-analytics.org/clinical/NCT00754065. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*